KNTPF
Price
$0.18
Change
-$0.03 (-14.29%)
Updated
Apr 7 closing price
Capitalization
82.91M
UNCY
Price
$4.58
Change
-$0.07 (-1.51%)
Updated
Jul 3, 12:57 PM (EDT)
Capitalization
59.12M
46 days until earnings call
Interact to see
Advertisement

KNTPF vs UNCY

Header iconKNTPF vs UNCY Comparison
Open Charts KNTPF vs UNCYBanner chart's image
KINTOR PHARMACEUTICAL
Price$0.18
Change-$0.03 (-14.29%)
Volume$750
Capitalization82.91M
Unicycive Therapeutics
Price$4.58
Change-$0.07 (-1.51%)
Volume$111
Capitalization59.12M
KNTPF vs UNCY Comparison Chart in %
Loading...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNTPF vs. UNCY commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTPF is a Buy and UNCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (KNTPF: $0.18 vs. UNCY: $4.63)
Brand notoriety: KNTPF and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTPF: 100% vs. UNCY: 158%
Market capitalization -- KNTPF: $82.91M vs. UNCY: $59.12M
KNTPF [@Biotechnology] is valued at $82.91M. UNCY’s [@Biotechnology] market capitalization is $59.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTPF’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • KNTPF’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, KNTPF is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNTPF’s TA Score shows that 2 TA indicator(s) are bullish while UNCY’s TA Score has 3 bullish TA indicator(s).

  • KNTPF’s TA Score: 2 bullish, 0 bearish.
  • UNCY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KNTPF is a better buy in the short-term than UNCY.

Price Growth

KNTPF (@Biotechnology) experienced а 0.00% price change this week, while UNCY (@Biotechnology) price change was -25.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +33.07%, and the average quarterly price growth was +3.79%.

Reported Earning Dates

UNCY is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($82.9M) has a higher market cap than UNCY($59.1M). KNTPF YTD gains are higher at: 10.875 vs. UNCY (-41.702).
KNTPFUNCYKNTPF / UNCY
Capitalization82.9M59.1M140%
EBITDAN/A-14.85M-
Gain YTD10.875-41.702-26%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A26.1M-
Total DebtN/A694K-
TECHNICAL ANALYSIS
Technical Analysis
KNTPFUNCY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHPMF1.56N/A
N/A
Shanghai Pharmaceuticals Holdings Co., Ltd.
SRBEF290.45N/A
N/A
VUSIONGROUP
STMRF1.27N/A
N/A
Stanmore Res Ltd
FGFI19.00N/A
N/A
First Greenwich Financial Inc.
ETCC1.41-0.02
-1.43%
Environmental Tectonics Corp.

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
MLEC - KNTPF
27%
Poorly correlated
-3.99%
KNSA - KNTPF
20%
Poorly correlated
+0.73%
UNCY - KNTPF
20%
Poorly correlated
-2.94%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
+2.80%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with CDTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-2.94%
CDTX - UNCY
52%
Loosely correlated
-2.45%
INDP - UNCY
51%
Loosely correlated
-3.23%
ICU - UNCY
45%
Loosely correlated
+15.46%
CERO - UNCY
37%
Loosely correlated
+2.28%
UTHR - UNCY
32%
Poorly correlated
+1.48%
More